Earnings Call Summary | Orthofix Medical(OFIX.US) Q2 2024 Earnings Conference
Earnings Call Summary | Orthofix Medical(OFIX.US) Q2 2024 Earnings Conference
Net revenue growth was primarily driven by strong performance in U.S. spine and Bone Growth Therapy businesses.The following is a summary of the Orthofix Medical Inc. (OFIX) Q2 2024 Earnings Call Transcript:
以下是Orthofix Medical Inc. (OFIX) Q2 2024業績會議要點：
Financial Performance:
金融業績：
Orthofix reported Q2 2024 net revenue of $198.6 million, a 6% growth on a constant currency basis.
Adjusted EBITDA margin expanded by approximately 310 basis points.
Net revenue growth was primarily driven by strong performance in U.S. spine and Bone Growth Therapy businesses.
Orthofix報告Q2 2024年貨幣不變基礎下淨營業收入爲19860萬美元，同比增長6%。
調整後的EBITDA毛利率擴大了約310個點子。
淨營業收入的增長主要是由於美國脊柱和骨生長療法業務的強勁表現。
Business Progress:
業務進展：
Orthofix has begun market release for two new interbody designs and received 510k clearances for Fitbone trochanteric nail and Fitbone transport and lengthening system, targeting a full launch in Q2 2025.
Integration with SeaSpine has been successful, including a key milestone of completing ERP system implementation.
The company is leveraging cross-functional leadership for strategic growth and focusing on innovation in 7D FLASH Navigation System.
Orthofix已開始市場推廣兩款新的椎體支架設計，並獲得了Fitbone股骨轉子釘和Fitbone運輸和延長系統的51萬個清關文件，計劃於2025年第二季度全面推出。
與SeaSpine的整合非常成功，包括完成ERP系統實施的關鍵里程碑。
該公司正在利用跨職能領導力實現戰略增長，並專注於7D FLASH導航系統的創新。
Opportunities:
機會：
Orthofix's integration with SeaSpine provides opportunities for cross-selling and expanding market reach.
The comprehensive product portfolio and steady innovation are expected to attract top sales talent and develop sticky surgeon and hospital relationships.
The 7D FLASH Navigation System offers unique opportunities in both open surgeries and ASC settings, expanding the potential customer base.
Orthofix與SeaSpine的整合爲跨銷售提供機會，擴大市場覆蓋範圍。
全面的產品組合和穩定的創新預計將吸引頂級銷售人才，並發展黏性外科醫生和醫院關係。
7D FLASH導航系統在開放手術和ASC環境中都提供獨特的機會，擴大了潛在客戶群。
Risks:
風險：
The incremental navigated procedure penetration of 7D FLASH Navigation System must compete with existing technologies and market conditions for surgical equipment.
7D FLASH導航系統的增量導航操作必須與現有技術和外科手術設備的市場條件競爭。
More details: Orthofix Medical IR
更多詳情請參見：orthofix medical IR
Tips: For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.
提示：如需更全面的詳情，請參閱投資人關係網站。本文僅供投資者參考，不作任何指引或建議。
譯文內容由第三人軟體翻譯。
